Your browser doesn't support javascript.
loading
PCR-Based Strategy for Introducing CRISPR/Cas9 Machinery into Hematopoietic Cell Lines.
González-Romero, Elisa; Martínez-Valiente, Cristina; García-García, Gema; Rosal-Vela, Antonio; Millán, José María; Sanz, Miguel Ángel; Sanz, Guillermo; Liquori, Alessandro; Cervera, José Vicente; Vázquez-Manrique, Rafael P.
Affiliation
  • González-Romero E; Hematology Research Group, Instituto de Investigación Sanitaria La Fe, 46026 Valencia, Spain.
  • Martínez-Valiente C; Hematology Research Group, Instituto de Investigación Sanitaria La Fe, 46026 Valencia, Spain.
  • García-García G; CIBERONC, 28029 Madrid, Spain.
  • Rosal-Vela A; Laboratory of Molecular, Cellular and Genomic Biomedicine, Instituto de Investigación Sanitaria La Fe, 46026 Valencia, Spain.
  • Millán JM; CIBERER, 46010 Valencia, Spain.
  • Sanz MÁ; Joint Unit for Rare Diseases IIS La Fe-CIPF, 46012 Valencia, Spain.
  • Sanz G; Hematology Research Group, Instituto de Investigación Sanitaria La Fe, 46026 Valencia, Spain.
  • Liquori A; Biomedicine, Biotechnology and Public Health Department, Cádiz University, 11002 Cádiz, Spain.
  • Cervera JV; Institute of Research and Innovation in Biomedical Sciences of Cadiz (INIBICA), 11009 Cádiz, Spain.
  • Vázquez-Manrique RP; Laboratory of Molecular, Cellular and Genomic Biomedicine, Instituto de Investigación Sanitaria La Fe, 46026 Valencia, Spain.
Cancers (Basel) ; 15(17)2023 Aug 25.
Article in En | MEDLINE | ID: mdl-37686539
Key words
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Cancers (Basel) Year: 2023 Type: Article Affiliation country: Spain
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Cancers (Basel) Year: 2023 Type: Article Affiliation country: Spain